Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Diseases | 5 | 2023 | 1304 | 1.620 |
Why?
|
Liver Function Tests | 2 | 2023 | 526 | 0.900 |
Why?
|
Carcinoma, Hepatocellular | 8 | 2024 | 2336 | 0.840 |
Why?
|
Liver Neoplasms | 8 | 2024 | 4365 | 0.670 |
Why?
|
Chimerism | 1 | 2019 | 156 | 0.600 |
Why?
|
Liver | 3 | 2023 | 7574 | 0.400 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1126 | 0.340 |
Why?
|
Epithelial Cells | 2 | 2019 | 3695 | 0.330 |
Why?
|
Neoplastic Cells, Circulating | 3 | 2020 | 957 | 0.290 |
Why?
|
Acute Disease | 1 | 2017 | 7242 | 0.270 |
Why?
|
End Stage Liver Disease | 2 | 2019 | 370 | 0.230 |
Why?
|
Waiting Lists | 3 | 2024 | 780 | 0.220 |
Why?
|
Esophageal and Gastric Varices | 1 | 2024 | 215 | 0.200 |
Why?
|
Liver Cirrhosis | 5 | 2024 | 1959 | 0.190 |
Why?
|
Liver Transplantation | 3 | 2024 | 2400 | 0.190 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2021 | 25 | 0.190 |
Why?
|
Hepatitis C, Chronic | 2 | 2020 | 1031 | 0.190 |
Why?
|
Dyskeratosis Congenita | 1 | 2021 | 70 | 0.180 |
Why?
|
Portal Pressure | 1 | 2020 | 62 | 0.180 |
Why?
|
HMGA2 Protein | 1 | 2020 | 101 | 0.170 |
Why?
|
Hypertension, Portal | 1 | 2020 | 230 | 0.150 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2024 | 1244 | 0.150 |
Why?
|
Attitude | 1 | 2019 | 772 | 0.110 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 750 | 0.110 |
Why?
|
Palliative Care | 2 | 2019 | 3643 | 0.110 |
Why?
|
Tissue Donors | 2 | 2020 | 2389 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2341 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2024 | 3587 | 0.100 |
Why?
|
Advance Care Planning | 1 | 2019 | 698 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1883 | 0.090 |
Why?
|
Cell Separation | 1 | 2017 | 1726 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 937 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2020 | 3627 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2020 | 3064 | 0.090 |
Why?
|
Hepatitis C | 1 | 2020 | 1593 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1755 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9510 | 0.080 |
Why?
|
Humans | 23 | 2024 | 768393 | 0.080 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5512 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4907 | 0.070 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2008 | 329 | 0.070 |
Why?
|
Heart | 1 | 2019 | 4449 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3267 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2019 | 3300 | 0.060 |
Why?
|
MicroRNAs | 1 | 2020 | 3804 | 0.060 |
Why?
|
Middle Aged | 7 | 2024 | 223491 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9379 | 0.050 |
Why?
|
Male | 10 | 2024 | 364902 | 0.050 |
Why?
|
Hepacivirus | 2 | 2020 | 1342 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5443 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3236 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2017 | 12805 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2023 | 332 | 0.050 |
Why?
|
Endoscopy, Digestive System | 1 | 2024 | 357 | 0.050 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2021 | 47 | 0.050 |
Why?
|
Female | 12 | 2024 | 397089 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15455 | 0.040 |
Why?
|
Hemodynamics | 2 | 2020 | 4199 | 0.040 |
Why?
|
Somatostatin | 1 | 2020 | 458 | 0.040 |
Why?
|
DNA Damage | 1 | 2008 | 2458 | 0.040 |
Why?
|
Aged | 5 | 2024 | 171562 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2952 | 0.040 |
Why?
|
Pyrrolidines | 1 | 2019 | 340 | 0.040 |
Why?
|
Quinoxalines | 1 | 2019 | 297 | 0.040 |
Why?
|
Cell Communication | 1 | 2024 | 1660 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2024 | 8634 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1839 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2017 | 378 | 0.030 |
Why?
|
Cultural Competency | 1 | 2019 | 303 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3922 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30228 | 0.030 |
Why?
|
Adult | 5 | 2024 | 223640 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2632 | 0.030 |
Why?
|
Observer Variation | 1 | 2020 | 2623 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2019 | 864 | 0.030 |
Why?
|
Signal Transduction | 2 | 2024 | 23631 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59686 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2079 | 0.030 |
Why?
|
Hepatitis B, Chronic | 1 | 2017 | 413 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 446 | 0.020 |
Why?
|
Prognosis | 2 | 2024 | 30022 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 81801 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10654 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3212 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2017 | 984 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6541 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4921 | 0.020 |
Why?
|
Sulfonamides | 1 | 2019 | 1980 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2038 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3413 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6006 | 0.020 |
Why?
|
United States | 3 | 2024 | 73150 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 17135 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8379 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5215 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2574 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26375 | 0.020 |
Why?
|
Gamma Rays | 1 | 2008 | 319 | 0.020 |
Why?
|
Mathematics | 1 | 2008 | 704 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 362 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4047 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2533 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14481 | 0.010 |
Why?
|
Communication | 1 | 2019 | 3912 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3666 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14154 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 60049 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24318 | 0.010 |
Why?
|
Imidazoles | 1 | 2008 | 1168 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13323 | 0.010 |
Why?
|
RNA Interference | 1 | 2008 | 2836 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2008 | 2812 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20765 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39407 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41795 | 0.010 |
Why?
|
Piperazines | 1 | 2008 | 2552 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40272 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2008 | 3458 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2008 | 3579 | 0.010 |
Why?
|
Animals | 2 | 2020 | 169337 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74962 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9614 | 0.010 |
Why?
|
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(91)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_